Could this vaccine stop the superbug gonorrhea?
NCT ID NCT05630859
First seen Jun 17, 2026 · Last updated Jun 17, 2026
Summary
This study tested an experimental gonorrhea vaccine in healthy adults aged 18 to 50. The goal was to see if the vaccine is safe and can prevent gonorrhea infections. Over 1,000 participants received either the vaccine or a placebo (salt water shot) and were monitored for side effects and infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEXUALLY TRANSMITTED DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Washington D.C., District of Columbia, 20009, United States
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Boston, Massachusetts, 02215, United States
-
GSK Investigational Site
Springfield, Missouri, 65802, United States
-
GSK Investigational Site
The Bronx, New York, 10467, United States
-
GSK Investigational Site
Pittsburgh, Pennsylvania, 48202, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Salvador, 41680-020, Brazil
-
GSK Investigational Site
Lyon, 69004, France
-
GSK Investigational Site
Paris, 75475, France
-
GSK Investigational Site
Pierre-Bénite, 69495, France
-
GSK Investigational Site
Bochum, 44787, Germany
-
GSK Investigational Site
Frankfurt, 60596, Germany
-
GSK Investigational Site
Hamburg, 20146, Germany
-
GSK Investigational Site
Manila, 1000, Philippines
-
GSK Investigational Site
Johannesburg, 2001, South Africa
-
GSK Investigational Site
Soweto, 2013, South Africa
-
GSK Investigational Site
Barcelona, 08015, Spain
-
GSK Investigational Site
Madrid, 28006, Spain
-
GSK Investigational Site
Madrid, 28040, Spain
-
GSK Investigational Site
Valencia, 46026, Spain
-
GSK Investigational Site
London, SW10 9NH, United Kingdom
-
GSK Investigational Site
London, WC1E 6JB, United Kingdom
Conditions
Explore the condition pages connected to this study.